Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. - Wikidata - awgldk - TriplyDB

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

http://www.wikidata.org/entity/Q39450022

about

Glycogen synthase kinase-3β is a pivotal mediator of cancer invasion and resistance to therapy Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma.Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway.MicroRNA-33a-mediated downregulation of Pim-3 kinase expression renders human pancreatic cancer cells sensitivity to gemcitabine.GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.Lithium inhibits tumor lymphangiogenesis and metastasis through the inhibition of TGFBIp expression in cancer cells Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.Comparative analysis of Notch1 and Notch2 binding sites in the genome of BxPC3 pancreatic cancer cells.MiR-410 induces stemness by inhibiting Gsk3β but upregulating β-catenin in non-small cells lung cancer.Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy.GSK-3 inhibition overcomes chemoresistance in human breast cancer.Assessment and optimization of electroporation-assisted tumoral nanoparticle uptake in a nude mouse model of pancreatic ductal adenocarcinoma.Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway.Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells.9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma.

P2860

Q26739711-3D082BF6-BBF2-41F3-B3B9-4B815737EDBE Q33618479-8CA1D66A-96CE-44FF-81BB-EFC40DDFF835 Q34585992-3C9AAA4B-5490-4416-97FB-9D387CDE28E5 Q34692166-53D4BB9D-35F6-4DDA-A010-9A961C571D57 Q35987380-96BB0F2B-7543-4B02-9B74-777C804313FD Q36272771-18DCB093-B812-4D79-B2B6-328389F153F5 Q36450022-AF65F3EE-C670-4C7C-992C-F158F9D6BF01 Q36559874-C915DC32-7088-469F-A90E-ACAF1DDA0478 Q37129787-C922EE18-79F7-49D5-BD83-CD25A287C4CE Q37139199-F952E65C-1AC2-459C-8C4D-F2D6894CD040 Q37604313-FC2E36E3-F95C-44CA-8E8C-0030D98E4CB0 Q37706915-90684760-E619-4D9B-A76E-9F4191BB331A Q37718335-D0071FA6-4E5B-49B1-B279-E55D2EEDD1B3 Q38221504-8C4DB584-7B9E-488E-BB75-D5B14C701C8B Q38757733-9C7077A1-1C84-4124-A42B-FE531911E193 Q38957259-09AFD185-9380-4DF0-B53E-E3259884782F Q39129195-62EE7C4D-2B84-43B1-BE2F-654A507054B9 Q42383020-896869EC-0929-4E01-8999-FACC301C7C2E Q54977208-6689CE8E-C06D-4FEB-96D9-2627DD049301 Q54977695-31593593-397D-4517-8E44-4914D3BC3700

P2860

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

http://www.wikidata.org/entity/Q39450022

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@en

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@nl

type

label

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@en

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@nl

prefLabel

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@en

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@nl

P1433

Q39450022-099EB752-6D74-4C5F-9779-7E428AFA5BCE

P1476

Q39450022-DA8D829B-BD28-41B9-B695-E5CA9A1C091C

P2093

Q39450022-0F79B008-0997-487E-AC1F-67834F3CE1F9

Q39450022-17A50E50-E3A1-4543-82F4-82C487A07C9C

Q39450022-1D05038E-F73F-4FCA-A966-54AE05B7F298

Q39450022-43F8415E-DB22-4637-B5FB-6E814919D5BD

Q39450022-4A062AC0-CA95-4140-9899-AF9B2672CE15

Q39450022-52758169-9810-455F-86BA-409F40C55E44

Q39450022-60E5D4E3-0736-40F7-9247-4F6B47E7813B

Q39450022-7101DF60-9B06-4DEB-BF4D-1EF667F6693C

Q39450022-99AA5891-46E9-4E60-AEE0-202A5CFE23EC

Q39450022-9D362686-B313-4187-A649-726AC2DF1769

P2860

Q39450022-046A5082-1FB0-4719-B186-55FA307FEA73

Q39450022-0778BABB-9AD2-4A81-B25B-9F0D646A91C3

Q39450022-09D5A9A6-5F6D-4808-95CD-32B1AF4DEBFC

Q39450022-0BF96545-D965-4030-899A-7F25AC381CF8

Q39450022-1C0B71E6-4462-4FD4-8FF4-F1ED2B1FA333

Q39450022-1E9A323D-7626-415D-AEE4-050F2F82D895

Q39450022-2471D064-0E97-42BD-9391-658FD01CD721

Q39450022-2E1EBC63-F123-411C-80A4-568BE3864736

Q39450022-314CD11D-5168-45C8-93E2-6742248A4D90

Q39450022-34BE3AE5-AB34-4200-85E9-BDFE4A30BC4F

P304

Q39450022-1886C650-DC2D-4A30-8374-A992EEA3E404

P31

Q39450022-FE3B6C50-3239-4A7B-8AE7-B0E5EFFCD355

P356

Q39450022-DD2BB262-A6FD-4907-B415-AB0AE046CCEF

P433

Q39450022-41CE9652-F244-4A64-AC7B-FD7C3E7865EA

P478

Q39450022-2BD7EB11-EED4-4AD2-A40D-BD3763C026B7

P577

Q39450022-AF52C161-DCEB-4F3C-94D0-CB3634B1294F

P5875

Q39450022-A570A153-BEF9-45CC-8708-CA6652B348A1

P698

Q39450022-67860781-2ED8-44AD-814F-B80F4A334BA4

P356

S00535-011-0484-9

P1433

Journal of Gastroenterology

P1476

Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.

@en

P2093

Ayako Kitano

http://www.w3.org/2001/XMLSchema#string

Hideo Nakajima

http://www.w3.org/2001/XMLSchema#string

Itaru Sato

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Kawakami

http://www.w3.org/2001/XMLSchema#string

Naohisa Tomosugi

http://www.w3.org/2001/XMLSchema#string

Naoki Nakaya

http://www.w3.org/2001/XMLSchema#string

Takanobu Takata

http://www.w3.org/2001/XMLSchema#string

Takeo Shimasaki

http://www.w3.org/2001/XMLSchema#string

Takuji Tanaka

http://www.w3.org/2001/XMLSchema#string

Toshinari Minamoto

http://www.w3.org/2001/XMLSchema#string

P2860

GSK-3: tricks of the trade for a multi-tasking kinase

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

Global cancer statistics, 2002

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death

Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function

p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis

Cancer statistics, 2007

P304

321-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-011-0484-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51759280

http://www.w3.org/2001/XMLSchema#string

P698

22041920

http://www.w3.org/2001/XMLSchema#string